chr22-19766765-CGCCGCGGCCGCCGCCGCCGCTGCCGCAGCT-C
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP3BP6BS1BS2
The NM_001379200.1(TBX1):c.1426_1455delGCCGCCGCTGCCGCAGCTGCCGCGGCCGCC(p.Ala476_Ala485del) variant causes a conservative inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000694 in 1,469,864 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000073 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000069 ( 2 hom. )
Consequence
TBX1
NM_001379200.1 conservative_inframe_deletion
NM_001379200.1 conservative_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.63
Genes affected
TBX1 (HGNC:11592): (T-box transcription factor 1) This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene product shares 98% amino acid sequence identity with the mouse ortholog. DiGeorge syndrome (DGS)/velocardiofacial syndrome (VCFS), a common congenital disorder characterized by neural-crest-related developmental defects, has been associated with deletions of chromosome 22q11.2, where this gene has been mapped. Studies using mouse models of DiGeorge syndrome suggest a major role for this gene in the molecular etiology of DGS/VCFS. Several alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001379200.1
BP6
Variant 22-19766765-CGCCGCGGCCGCCGCCGCCGCTGCCGCAGCT-C is Benign according to our data. Variant chr22-19766765-CGCCGCGGCCGCCGCCGCCGCTGCCGCAGCT-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 518565.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0000727 (11/151264) while in subpopulation SAS AF= 0.00104 (5/4820). AF 95% confidence interval is 0.000408. There are 0 homozygotes in gnomad4. There are 7 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 11 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBX1 | NM_001379200.1 | c.1426_1455delGCCGCCGCTGCCGCAGCTGCCGCGGCCGCC | p.Ala476_Ala485del | conservative_inframe_deletion | 7/7 | ENST00000649276.2 | NP_001366129.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBX1 | ENST00000649276.2 | c.1426_1455delGCCGCCGCTGCCGCAGCTGCCGCGGCCGCC | p.Ala476_Ala485del | conservative_inframe_deletion | 7/7 | NM_001379200.1 | ENSP00000497003.1 | |||
TBX1 | ENST00000332710.8 | c.1399_1428delGCCGCCGCTGCCGCAGCTGCCGCGGCCGCC | p.Ala467_Ala476del | conservative_inframe_deletion | 9/9 | 1 | ENSP00000331791.4 | |||
TBX1 | ENST00000329705.11 | c.1009+776_1009+805delGCCGCCGCTGCCGCAGCTGCCGCGGCCGCC | intron_variant | 1 | ENSP00000331176.7 | |||||
TBX1 | ENST00000359500.7 | c.1009+776_1009+805delGCCGCCGCTGCCGCAGCTGCCGCGGCCGCC | intron_variant | 1 | ENSP00000352483.3 |
Frequencies
GnomAD3 genomes AF: 0.0000727 AC: 11AN: 151264Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
11
AN:
151264
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000302 AC: 25AN: 82690Hom.: 1 AF XY: 0.000375 AC XY: 18AN XY: 48000
GnomAD3 exomes
AF:
AC:
25
AN:
82690
Hom.:
AF XY:
AC XY:
18
AN XY:
48000
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000690 AC: 91AN: 1318600Hom.: 2 AF XY: 0.0000767 AC XY: 50AN XY: 651514
GnomAD4 exome
AF:
AC:
91
AN:
1318600
Hom.:
AF XY:
AC XY:
50
AN XY:
651514
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000727 AC: 11AN: 151264Hom.: 0 Cov.: 33 AF XY: 0.0000948 AC XY: 7AN XY: 73844
GnomAD4 genome
AF:
AC:
11
AN:
151264
Hom.:
Cov.:
33
AF XY:
AC XY:
7
AN XY:
73844
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
DiGeorge syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 06, 2024 | This variant, c.1399_1428del, results in the deletion of 10 amino acid(s) of the TBX1 protein (p.Ala467_Ala476del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs746335599, gnomAD 0.05%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with TBX1-related conditions. ClinVar contains an entry for this variant (Variation ID: 518565). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at